ϩ
1
430, 1100–1270 and 910; δ (56.4 MHz; CDCl ; CFCl ) Ϫ65.7
494/496 (M , 100.00/35.6%), 466/468 (23.04/8.30), 422/424
(47.93/16.73).
F
3
3
(
2 F, s, ClCF ), Ϫ95.2 (2 F, s, ClCF CF CF ), Ϫ125.8 (2 F, s,
2 2 2 2
ClCF CF ); δ (300 MHz; CDCl ; Me Si) 8.38 [1 H, d, J 9.1,
2
2
H
3
4
C(5)-H], 6.60–7.70 (8 H, m, ArH), 4.38 (2 H, q, J 7.2,
OCH CH ), 1.41 (3 H, t, J 7.2, OCH CH ); m/z (EI) 449/451
Diethyl
indolizine-1,7-dicarboxylate 3d and diethyl 2-(3-chloro-1,2,2,3,3-
pentafluoropropyl)-3-phenylindolizine-1,7-dicarboxylate 4d.
2-(3-chloro-1,1,2,2,3,3-hexafluoropropyl)-3-phenyl-
2
3
2
3
ϩ
(
M , 100.00/35.06%), 421/423 (5.81/1.98), 404/406 (29.09/9.59),
3
77/379 (25.01/8.14), 248 (84.58).
Using the general procedure with ethyl 3-(3-chloro-1,1,2,2,3,3-
hexafluoropropyl)-3-fluoroacrylate 1a (303 mg, 1 mmol) and
N-benzyl-4-(ethoxycarbonyl)pyridinium bromide 2d (388 mg,
1.2 mmol) followed by flash column chromatography using
Ethyl 2-(3-chloro-1,1,2,2,3,3-hexafluoropropyl)-3-(4-methoxy-
phenyl)indolizine-1-carboxylate 3b and ethyl 2-(3-chloro-1,2,2,3,3-
pentafluoropropyl)-3-(4-methoxyphenyl)indolizine-1-carboxylate
hexane–EtOAc (10 : 1; R = 0.5–0.6) as eluant first afforded
f
4
b. Using the general procedure with ethyl 3-(3-chloro-1,1,2,2,3,3-
hexafluoropropyl)-3-fluoroacrylate 1a (303 mg, 1 mmol) and N-
4-methoxybenzyl)pyridinium bromide 2b (336 mg, 1.2 mmol)
compound 4d (40 mg, 0.08 mmol, 8%) as a light yellow solid,
Ϫ1
mp 118.0–119.0 ЊC; νmax(KBr)/cm 2978, 1711, 1687, 1519,
(
1027–1315 and 764; δF (282.0 MHz; CDCl ; CFCl ) Ϫ68.7
3
3
followed by flash column chromatography using hexane–
(2 F, s, ClCF ), Ϫ114.4, Ϫ125.2 (2 F, AB system, J 274.5,
2
EtOAc (10 : 1; R = 0.4–0.5) as eluant first afforded compound
ClCF CF ), Ϫ191.7 (1 F, m, ClCF CF CFH); δ (300 Hz;
f
2
2
2
2
H
4
b (82 mg, 0.18 mmol, 18%) as a white solid, mp 109.1–112.5 ЊC
CDCl ; Me Si) 9.08 [1 H, s, C(8)-H], 7.13–7.72 (7 H, m, ArH
3 4
(
5
1
Found: C, 54.60; H, 3.58; N, 2.87. C H ClF NO requires C,
and CFH), 4.31–4.58 (4 H, m, 2 × OCH CH ), 1.31–1.58 (6 H,
2 3
ϩ
21
17
Ϫ1
5
3
4.62; H, 3.71; N, 3.03%); νmax(KBr)/cm 2980, 1666, 1610,
569, 1498, 1038–1324; δ (282.0 MHz; CDCl ; CFCl ) Ϫ68.6
m, 2 × OCH CH ); m/z (EI) 503.091 79 (M . C H ClF NO
2 3 23 19 5 4
requires M, 503.092 28), 505 (39.92%), 475/477 (9.78/3.51),
F
3
3
(
2 F, s, ClCF ), Ϫ114.5, Ϫ125.3 (2 F, AB system, J 274.3,
458/460 (17.36/6.24), 431/433 (15.13/4.99). Then furnished
2
ClCF CF ), Ϫ191.3 (1 F, m, ClCF CF CFH); δ (300 MHz;
compound 3d (10 : 1; R = 0.4–0.5) as a light yellow solid
2
2
2
2
H
f
CDCl ; Me Si) 8.29 [1 H, d, J 9.0, C(5)-H], 7.66 [1 H, d, J 7.1,
(182 mg, 0.35 mmol, 35%), mp 70.0–73.0 ЊC (Found: C, 53.12;
3
4
C(8)-H], 6.94–7.48 (7 H, m, ArH and CFH), 4.44 (2 H, q, J 7.3,
OCH CH ), 3.90 (3 H, s, OCH ), 1.43 (3 H, t, J 7.3, OCH CH );
H, 3.50; N, 2.63. C H ClF NO requires C, 52.94; H, 3.48;
23
18
6
4
Ϫ1
N, 2.68%); νmax(KBr)/cm 2924, 1714, 1521, 1184–1316 and
761; δ (56.4 MHz; CDCl ; CFCl ) Ϫ67.0 (2 F, s, ClCF ), Ϫ97.4
2
3
3
2
3
ϩ
m/z (EI) 461/463 (M , 100.00/38.79%), 433/435 (2.37/0.88),
16/418 (12.07/5.44), 389/391 (12.98/4.59), 278 (26.12). Then
F
3
3
2
4
(2 F, s, ClCF CF CF ), Ϫ116.6 (2 F, s, ClCF CF ); δ
2 2 2 2 2 H
was furnished compound 3b (10 : 1; R = 0.3–0.4) as a white
solid (148 mg, 0.31 mmol, 31%), mp 81.0–83.5 ЊC (Found: C,
(300 MHz; CDCl ; Me Si) 9.09 [1H, s, C(8)-H], 7.18–7.68 (7 H,
3 4
f
m, ArH), 4.31–4.58 (4 H, m, 2 × OCH CH ), 1.31–1.58 (6 H, m,
2 3
ϩ
5
3
1
2.70; H, 3.19; N, 2.80. C H ClF NO requires C, 52.67; H,
2 × OCH CH ); m/z (EI) 521/523 (M , 100.00/38.00%), 476/478
2 3
21
16
Ϫ1
6
3
.36; N, 2.92%); νmax(KBr)/cm 2999, 1705, 1610, 1555, 1505,
058–1328 and 867; δ (56.4 MHz; CDCl ; CFCl ) Ϫ65.5 (2 F,
(21.52/7.69), 448/450 (23.54/11.54), 310 (16.64).
F
3
3
s, ClCF ), Ϫ96.4 (2 F, s, ClCF CF CF ), Ϫ115.7 (2 F, s,
Ethyl 2-(3-chloro-1,1,2,2,3,3-hexafluoropropyl)-7-methyl-3-(4-
nitrophenyl)indolizine-1-carboxylate 3e. Using the general
procedure with ethyl 3-(3-chloro-1,1,2,2,3,3-hexafluoropropyl)-
3-fluoroacrylate 1a (303 mg, 1 mmol) and 4-methyl-N-(4-
nitrobenzyl)pyridinium bromide 2e (370 mg, 1.2 mmol)
followed by flash column chromatography using hexane–
2
2
2
2
ClCF CF ); δ (300 MHz; CDCl ; Me Si) 8.34 [1 H, d, J 9.0,
2
2
H
3
4
C(5)-H], 7.51 [1 H, d, J 7.3, C(8)-H], 6.58–7.49 (6 H, m,
ArH), 4.41(2 H, q, J 7.3, OCH CH ), 3.91 (3 H, s, OCH ), 1.41
2
3
3
ϩ
(
3 H, t, J 7.3, OCH CH ); m/z (EI) 479/481 (M , 100.00/38.9%),
2 3
4
2
51/453 (4.06/1.42), 434/436 (13.55/5.47), 407/409 (11.87/3.97),
96 (14.48).
EtOAc (10 : 1; R = 0.1–0.2) as eluant afforded compound 3e
f
(
25 mg, 0.05 mmol, 5%) as a yellow solid, mp 166.0–168.0 ЊC
Ethyl
2-(3-chloro-1,1,2,2,3,3-hexafluoropropyl)-3-(4-nitro-
(Found: C, 49.72; H, 3.10; N, 5.30. C H ClF NO requires C,
21
15
Ϫ1
6
4
phenyl)indolizine-1-carboxylate 3c and ethyl 2-(3-chloro-1,2,2,3,3-
pentafluoropropyl)-3-(4-nitrophenyl)indolizine-1-carboxylate 4c.
Using the general procedure with ethyl 3-(3-chloro-1,1,2,2,3,3-
hexafluoropropyl)-3-fluoroacrylate 1a (303 mg, 1 mmol) and
N-(4-nitrobenzyl)pyridinium bromide 2c (354 mg, 1.2 mmol)
followed by flash column chromatography using hexane–
49.57; H, 2.97; N, 5.51%); νmax(KBr)/cm 1679, 1600, 1515,
1057–1350 and 854; δ (56.4 MHz; CDCl ; CFCl ) Ϫ65.8 (2 F,
F
3
3
s, ClCF ), Ϫ96.1 (2 F, s, ClCF CF CF ), Ϫ115.8 (2 F, s,
2
2
2
2
ClCF CF ); δ (300 MHz; CDCl ; Me Si) 8.40 (2 H, d,
2
2
H
3
4
J 8.9, 2 × o-NO C H H), 8.21 [1 H, s, C(8)-H)], 7.61 (2 H,
2
6
3
d, J 8.9, 2 × m-NO C H H), 7.35 [1 H, d, J 7.1, C(5)-H], 6.61
2
6
3
EtOAc (7 : 1; R = 0.3–0.4) as eluent first afforded compound 4c
[1 H, d, J 7.1, C(6)-H], 4.40 (2 H, q, J 7.3, OCH CH ), 2.41
f
2 3
(
138 mg, 0.29 mmol, 29%) as a yellow solid, mp 172.0–174.0 ЊC
[3 H, s, C(7)-CH ], 1.41 (3 H, t, J 7.3, OCH CH ); m/z (EI)
3 2 3
ϩ
508/510 (M , 100.00/38.9%), 480/482 (23.91/8.06), 463/465
(33.09/11.34), 436/438 (49.06/16.77).
(
5
1
Found: C, 50.53; H, 3.05; N, 5.83. C H ClF N O requires C,
0.38; H, 2.95; N, 5.87%); νmax(KBr)/cm 1680, 1592, 1502,
20
14
5
2
4
Ϫ1
100–1280 and 771; δF (282.0 MHz; CDCl ; CFCl ) Ϫ68.8
3
3
(
2 F, s, ClCF ), Ϫ114.7, Ϫ125.4 (2 F, AB system, J 275.1,
Diethyl 2-(3-chloro-1,1,2,2,3,3-hexafluoropropyl)-3-(4-nitro-
phenyl)indolizine-1,7-dicarboxylate 3f. Using the general
procedure with ethyl 3-(3-chloro-1,1,2,2,3,3-hexafluoropropyl)-
3-fluoroacrylate 1a (303 mg, 1 mmol) and 4-ethoxycarbonyl-
N-(4-nitrobenzyl)pyridinium bromide 2f (440 mg, 1.2 mmol)
followed by flash column chromatography using hexane–
2
ClCF CF ), Ϫ189.8 (1 F, m, ClCF CF CFH); δ (300 MHz;
CDCl ; Me Si) 8.36–8.43 [3 H, m, C(5)-H and 2 × o-NO
C H H], 7.64–7.69 [3 H, m, C(8)-H and 2 × m-NO C H H],
7
4
2
2
2
2
H
3
4
2
6
3
2
6
3
.41 (1 H, dd, J 43.6 and 21.0, CFH), 6.78–7.25 (2 H, m, ArH),
.50 (2 H, q, J 7.0, OCH CH ), 1.49 (3 H, t, J 7.0, OCH CH );
2
3
2
3
ϩ
m/z (EI) 476/478 (M , 100.00/35.06%), 448/450 (14.67/5.16),
31/433 (24.37/8.14). Then was furnished compound 3c (7 : 1;
EtOAc (5 : 1; R = 0.4–0.5) as eluant afforded compound 3f
f
4
(187 mg, 0.33 mmol, 33%) as a yellow solid, mp 153.0–155.0 ЊC
R = 0.2–0.3) as a yellow solid (153 mg, 0.31 mmol, 31%),
mp 195.5–197.0 ЊC (Found: C, 48.57; H, 2.67; N, 5.52.
(Found: C, 48.72; H, 3.14; N, 4.83. C H ClF N O requires C,
f
23 17
6
2
6
Ϫ1
48.74; H, 3.02; N, 4.94%); νmax(KBr)/cm 2984, 1716, 1602,
1518 and 1027–1314; δ (56.4 MHz; CDCl ; CFCl ) Ϫ65.8 (2 F,
C H ClF N O requires C, 48.55; H, 2.65; N, 5.66%);
2
0
13
6
2
4
F
3
3
Ϫ1
νmax(KBr)/cm 1670, 1594, 1500, 1100–1257 and 759; δ (56.4
s, ClCF ), Ϫ96.8 (2 F, s, ClCF CF CF ), Ϫ115.8 (2 F, s,
F
2
2
2
2
MHz; CDCl ; CFCl ) Ϫ66.0 (2 F, s, ClCF ), Ϫ96.3 (2 F, s,
ClCF CF ); δ (300 MHz; CDCl ; Me Si) 9.10 [1 H, s, C(8)-H],
2 2 H 3 4
3
3
2
ClCF CF CF ), Ϫ115.8 (2 F, s, ClCF CF ); δ (300 MHz;
8.43 (2 H, d, J 8.7, 2 × o-NO C H H), 7.62 (2 H, d, J 8.7, 2 ×
2
2
2
2
2
H
2 6 3
CDCl ; Me Si) 8.42–8.45 [3 H, m, C(5)-H and 2 × o-NO -
m-NO C H H), 7.46 [1 H, d, J 7.3, C(5)-H], 7.29 [1 H, d, J 7.3,
2 6 3
3
4
2
C H H], 7.62 (2 H, d, J 9.0, 2 × m-NO C H H], 7.46 [1 H,
C(6)-H], 4.40–4.47 (4 H, m, 2 × OCH CH ), 1.41–1.47 (6 H, m,
2 3
ϩ
6
3
2
6
3
d, J 6.8, C(8)-H], 6.80–7.25 (2 H, m, ArH), 4.40 (2 H, q,
J 7.5, OCH CH ), 1.46 (3 H, t, J 7.5, OCH CH ); m/z (EI)
2 × OCH CH ); m/z (EI) 566/568 (M , 100.00/35.85%), 538/540
2 3
(19.32/6.58), 521/523 (35.85/12.86), 494/496 (53.41/18.82).
2
3
2
3
3
208
J. Chem. Soc., Perkin Trans. 1, 2001, 3204–3210